Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This will be a single center, open label, exploratory research study to assess the dermal
pharmacokinetic (PK) profile of three marketed diclofenac products in 26 healthy volunteers
using dermal open flow microperfusion (dOFM).
This clinical study aims to assess bioequivalence (BE) of three different diclofenac
products.